Press releases
-
-
-
Internal link ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025
-
-
-
-
-
-
-
-
-
Internal link ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth
-
-
Internal link ProQR Announces Amendment to Convertible Debt Financing Agreement with Pontifax Ventures and Kreos Capital
-
Internal link ProQR Announces First Patients Dosed in Phase 2/3 Pivotal Trials of QR-421a for USH2A Mediated Retinitis Pigmentosa
-
Internal link ProQR Announces Highlights from Analyst Event
-
Internal link ProQR to Webcast Virtual Analyst Event on November 18
-
-
-
-
-
-
Internal link ProQR Announces Virtual Presentation at EURETINA 2021
-
Internal link ProQR Announces Upcoming Investor Conferences
-
Internal link ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual Conference